Related Experiment Videos

[Molecular marker for detecting hypercoagulable state]

Y Magari1, S Mizunaga, M Ito

  • 1Department of Laboratory Medicine, Oita Medical University.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|January 1, 1994
PubMed

Insights

New molecular markers like FM.Oita and FDP.Oita can detect hypercoagulable states. These markers, measuring both coagulation and fibrinolysis, offer a more detailed indicator of thrombotic risk than existing methods.

Area of Science:

  • Biochemistry
  • Hematology
  • Clinical Chemistry

Context:

  • Intravascular coagulation and fibrinolysis are critical in various diseases.
  • Early detection of hypercoagulable and pre-thrombotic states is crucial for patient outcomes.
  • Existing markers may lack the sensitivity or specificity for early detection.

Purpose:

  • To identify sensitive molecular markers for assessing intravascular coagulative-fibrinolytic activity.
  • To compare the diagnostic utility of novel assays (FM.Oita, SFMC.Oita, FDP.Oita) with existing methods.
  • To establish reliable indicators for early detection of hypercoagulable and pre-thrombotic states.

Summary:

  • Assessed coagulative and fibrinolytic markers in patients with DIC, thrombosis, AMI, sepsis, cancer, and diabetes.
  • Found increased coagulative and fibrinolytic activity in all disease groups compared to healthy subjects.
  • Identified soluble fibrin monomer complexes (FM.Oita, SFMC.Oita) and thrombin-antithrombin III complex (TAT) as key coagulation markers, and FDP.Oita as a sensitive fibrinolytic marker.

Impact:

  • FM.Oita and FDP.Oita show a strong correlation, offering a more detailed indicator of coagulative-fibrinolytic balance than traditional ratios.
  • High-sensitivity assays like FDP.Oita demonstrate superior detection sensitivity compared to commercially available methods.
  • Establishing criteria based on these markers could lead to earlier diagnosis and intervention for thrombotic disorders.

Related Concept Videos